Solara Active Pharma Sciences (NSE:SOLARA) Interest Expense : ₹-1,086 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Solara Active Pharma Sciences's interest expense for the three months ended in Sep. 2024 was ₹ -283 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-1,086 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Solara Active Pharma Sciences's Operating Income for the three months ended in Sep. 2024 was ₹ 360 Mil. Solara Active Pharma Sciences's Interest Expense for the three months ended in Sep. 2024 was ₹ -283 Mil. Solara Active Pharma Sciences's Interest Coverage for the quarter that ended in Sep. 2024 was 1.27. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Solara Active Pharma Sciences Interest Expense Historical Data

The historical data trend for Solara Active Pharma Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Interest Expense Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-676.50

-802.40

-672.80

-833.80

-985.20

Solara Active Pharma Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-244.40	-253.70	-241.00	-308.70	-282.80

Solara Active Pharma Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,086 Mil.

Solara Active Pharma Sciences (NSE:SOLARA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Solara Active Pharma Sciences's Interest Expense for the three months ended in Sep. 2024 was ₹-283 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₹360 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ₹973 Mil.

Solara Active Pharma Sciences's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2024 )	/	Interest Expense (Q: Sep. 2024 )
	=	-1	*	359.7	/	-282.8
	=	1.27

The higher the ratio, the stronger the company's financial strength is.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARA) » Definitions » Interest Expense

Traded in Other Exchanges

SOLARAPP:India 890202:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines